alemtuzumab

Related by string. Alemtuzumab * * alemtuzumab treated . alemtuzumab MS . comparing alemtuzumab . Campath alemtuzumab . Genzyme alemtuzumab biologic . alemtuzumab Campath *

Related by context. All words. (Click for frequent words.) 70 Campath 67 daclizumab 66 Alemtuzumab 65 Amrubicin 64 FTY# 63 decitabine 63 HuMax CD4 63 Revlimid 62 Fludara 62 Treanda 62 elotuzumab 62 pomalidomide 62 natalizumab 62 rituximab 62 Abraxane 62 HuMax CD# 62 BAY #-# 62 mipomersen 62 sunitinib 62 denosumab 61 lumiliximab 61 relapsing remitting multiple sclerosis 61 panitumumab 61 darapladib 61 LymphoStat B 61 Dacogen 61 atacicept 61 TroVax 61 Rituxan 61 febuxostat 61 bevacizumab Avastin 60 Amigal 60 lapatinib 60 Kuvan 60 Cimzia 60 amrubicin 60 Vidaza 60 vandetanib 60 figitumumab 60 Mylotarg 60 Orencia 60 Torisel 60 methylnaltrexone 60 octreotide 60 Hematide 60 PXD# 60 etanercept 60 axitinib 60 Golimumab 60 lupus nephritis 60 eltrombopag 60 Natalizumab 60 Traficet EN 60 Rebif 59 bendamustine 59 metastatic renal cell carcinoma 59 Leukine 59 INCB# [002] 59 Campath alemtuzumab 59 COPAXONE R 59 cabazitaxel 59 epoetin 59 adalimumab 59 pazopanib 59 PROMACTA 59 FOLOTYN 59 Revlimid lenalidomide 59 bapineuzumab 59 Laquinimod 59 Plicera 59 azacitidine 59 Tavocept 59 Herceptin trastuzumab 59 sorafenib 59 romiplostim 59 romidepsin 59 ofatumumab 59 Nuvion 59 MabCampath 59 rotigotine 59 INCB# [001] 59 Clolar 59 fingolimod 59 Entereg 59 carfilzomib 59 regorafenib 59 cediranib 59 relapsing MS 59 temsirolimus 59 Ocrelizumab 59 tafamidis 59 OPAXIO 59 anakinra 59 chlorambucil 59 sapacitabine 59 Promacta 59 vismodegib 58 ocrelizumab 58 teriflunomide 58 Fampridine SR 58 HER2 positive metastatic breast 58 ACZ# 58 iloperidone 58 pegylated interferons 58 galiximab 58 cladribine 58 relapsing multiple sclerosis 58 Vectibix 58 iniparib 58 ELND# 58 Stimuvax 58 PEG Interferon lambda 58 Bevacizumab 58 tasocitinib 58 anti TNF 58 chronic lymphocytic leukemia CLL 58 Rebif ® 58 Erbitux 58 interferon beta 58 rituximab Rituxan 58 trastuzumab 58 YERVOY 58 pramlintide 58 Folotyn 58 mycophenolate mofetil 58 infliximab 58 Actemra 58 tocilizumab 58 Taxotere ® 58 docetaxel 58 VIDAZA 58 sitagliptin 58 Arcalyst 58 octreotide LAR 58 ixabepilone 58 valopicitabine 58 cholinesterase inhibitors 58 otelixizumab 58 Xanafide 58 Genentech Rituxan 58 dirucotide 58 cetuximab 58 Xinlay 58 Telcyta 58 ipilimumab 58 TYKERB 58 teduglutide 58 MBP# [001] 58 DAPT 58 bifeprunox 58 nilotinib 58 RG# [001] 58 Velcade bortezomib 58 MIRCERA 58 Genasense 57 AGILECT R 57 MGCD# [001] 57 Dasatinib 57 MGd 57 sirolimus 57 Dacogen injection 57 glufosfamide 57 Daclizumab 57 interferon therapy 57 COPAXONE ® 57 Cethrin 57 Tykerb 57 picoplatin 57 alemtuzumab treated 57 vidofludimus 57 mitoxantrone 57 calcineurin inhibitor 57 ProSavin 57 Novartis Zometa 57 tofacitinib 57 Doxil 57 Novantrone 57 VAPRISOL 57 Bortezomib 57 TRISENOX 57 baminercept 57 topotecan 57 recurrent GBM 57 TYSABRI 57 mapatumumab 57 YONDELIS 57 Phenoptin 57 enzastaurin 57 Prochymal 57 alemtuzumab Campath 57 TNF alpha inhibitors 57 liraglutide 57 XL# [003] 57 Firazyr 57 Genz # 57 BRAF inhibitor 57 Targretin 57 alvimopan 57 AZD# 57 Sprycel 57 Arranon 57 oxaliplatin 57 FOLPI 57 FOLFIRINOX 57 allopurinol 57 imetelstat 57 deforolimus 57 ASA# 57 bosentan 57 Increlex R 57 Campath ® 57 EGFR inhibitors 57 BRIM2 57 zoledronic acid 57 xanthine oxidase inhibitor 57 dasatinib 57 peginterferon 57 elacytarabine 57 Sorafenib 57 XmAb# 57 Rituximab 57 sipuleucel T 57 LY# [003] 57 LAF# 57 disease modifying 57 Avastin 57 biologic therapy 57 proteasome inhibitor 57 entecavir 57 prasugrel 57 posaconazole 57 vorinostat 57 phase IIb clinical 57 CANCIDAS 57 olaparib 57 dacarbazine 57 Betaferon 57 lubiprostone 57 sorafenib Nexavar 57 ONTAK 57 dimebon 57 ACTEMRA 56 sunitinib malate 56 Stelara 56 Rezular 56 imatinib 56 telbivudine 56 Allovectin 7 ® 56 G CSF 56 Syncria 56 bortezomib 56 ganetespib 56 Xcytrin 56 relapsing remitting MS 56 bevacizumab 56 Denosumab 56 Etanercept 56 Avastin bevacizumab 56 HuLuc# 56 abiraterone 56 tolvaptan 56 gefitinib Iressa 56 dacarbazine chemotherapy 56 Sandostatin LAR 56 ZD# [001] 56 Albuferon 56 Corlux 56 gemcitabine 56 Increlex 56 Nexavar 56 TNF inhibitors 56 Zolinza 56 phase IIa clinical 56 Ixempra 56 B CLL 56 laquinimod 56 tremelimumab 56 goserelin 56 relapsed SCLC 56 obatoclax 56 Aflibercept 56 pioglitazone 56 riociguat 56 pralatrexate 56 TREANDA 56 mRCC 56 monotherapy 56 PEGylated interferon beta 1a 56 visilizumab 56 tanespimycin 56 clofarabine 56 T DM1 56 antidiabetic therapy 56 midstage clinical 56 CoFactor 56 Gilenya 56 Fampridine 56 abatacept 56 custirsen 56 Nexavar ® 56 MyVax R 56 pertuzumab 56 anastrozole 56 TroVax ® 56 efalizumab 56 Velcade 56 GVAX 56 docetaxel chemotherapy 56 bezafibrate 56 adalimumab Humira 56 calcineurin inhibitors 56 solanezumab 56 omalizumab 56 Multaq R 56 UCB Cimzia 56 MNTX 56 apremilast 56 PLX# 56 Asentar 56 Tysabri 56 elagolix 56 hypomethylating agents 56 MabThera 56 Mipomersen 56 myelodysplastic syndromes 56 entinostat 56 cutaneous T cell 56 TELCYTA 56 AZILECT R 56 lintuzumab 56 telaprevir 56 cilengitide 56 Yervoy 56 CIMZIA TM 56 ADVEXIN 56 SinuNase 56 Tarceva erlotinib 56 interferon beta 1b 56 Alzhemed TM 56 RAPTIVA 56 glatiramer acetate 56 pregabalin 56 PEG INTRON 56 pramipexole 56 atypical antipsychotic 56 trabectedin 56 viral kinetics 56 low dose cytarabine 56 VPRIV 56 MYDICAR 56 adecatumumab 56 Bezielle 56 Gamunex 56 CsA 56 tesmilifene 56 ibandronate 56 Gleevec imatinib mesylate 56 vinorelbine 56 antipsychotic 56 Arixtra 56 indolent NHL 56 peginesatide 56 ambrisentan 56 davunetide 56 Jevtana 56 homozygous familial hypercholesterolemia 56 tyrosine kinase inhibitor 56 eculizumab 56 rufinamide 56 losartan 56 AP# [003] 55 beta interferon 55 Telintra 55 lymphoma CTCL 55 Vaprisol 55 epoetin alfa 55 Reverset 55 chronic angina 55 memantine 55 intermittent dosing 55 fludarabine 55 insulin glargine 55 CCX# 55 REMICADE ® 55 safinamide 55 AEGR 55 RDEA# 55 fenofibrate 55 Avonex interferon beta 1a 55 ponatinib 55 Gleevec Glivec 55 perifosine 55 Zerenex 55 Evoltra 55 taxanes 55 Irinotecan 55 DMARD 55 sargramostim 55 CIMZIA ™ 55 insulin detemir 55 ataluren 55 Increlex ® 55 canagliflozin 55 Canvaxin 55 Phase Ib clinical 55 Ceflatonin 55 GSK# [001] 55 TORISEL 55 RSR# 55 tivozanib 55 Pfizer Sutent 55 dapagliflozin 55 aflibercept 55 C1 INH 55 pegaptanib 55 velaglucerase alfa 55 Betaseron 55 TEMODAL 55 castration resistant prostate cancer 55 Phase 2b trial 55 dirucotide MBP# 55 interferon beta 1a 55 GAMMAGARD LIQUID 55 ximelagatran 55 Betaferon ® 55 TACI Ig 55 imatinib Gleevec 55 Gilenia 55 Avonex 55 Xyotax 55 TNF antagonist 55 canakinumab 55 Phase 2a trial 55 JAK inhibitor 55 adefovir 55 Tarceva 55 Cimzia ® certolizumab pegol 55 PD LID 55 FOLFOX 55 elesclomol 55 Integrilin 55 Gattex 55 heterozygous FH 55 Azedra 55 interferon 55 chemoradiotherapy 55 DMARDs 55 pitavastatin 55 interferon gamma 1b 55 metformin 55 TRIOLEX 55 APPRAISE 55 SUTENT 55 CA4P 55 GnRH agonists 55 temozolomide 55 Hodgkin lymphoma HL 55 Taxotere 55 calcitriol 55 Miraxion 55 Votrient 55 phase IIb trial 55 forodesine 55 FOLFOX4 55 tamibarotene 55 tiotropium 55 Vectibix panitumumab 55 dacetuzumab 55 perampanel 55 Teriflunomide 55 PRT# 55 bone metastases 55 Celgene Revlimid 55 Macugen 55 rFVIIa 55 VELCADE 55 Gleevec resistant 55 Fludarabine 55 ORENCIA R 55 adverse cytogenetics 55 metastatic HRPC 55 XYOTAX 55 Doxil ® 55 samalizumab 55 leflunomide 55 Advexin 55 MADIT II 55 CR# vcMMAE 55 Symadex 55 Remicade 55 GAMMAGARD 55 tarenflurbil 55 senicapoc 55 receptor tyrosine kinase inhibitor 55 panobinostat 55 aprepitant 55 L BLP# 55 NSCLC 55 lacosamide 55 SRT# [003] 55 Dapagliflozin 55 Catena ® 55 teriparatide 55 muraglitazar 55 Afinitor 55 XELOX 55 fondaparinux 55 relapsed CLL 55 subcutaneously administered 55 GATTEX 55 Phase Ib study 55 OvaRex ® MAb 55 Iressa 55 Vilazodone 55 cangrelor 55 carboplatin paclitaxel 55 exenatide 55 Dendreon Provenge 55 Remodulin 55 docetaxel Taxotere R 55 zalutumumab 54 myelodysplastic syndrome MDS 54 tyrosine kinase inhibitors 54 oxaliplatin Eloxatin 54 HoFH 54 diabetic neuropathic pain 54 cetuximab Erbitux 54 bardoxolone 54 rindopepimut 54 Mozobil 54 PTK ZK 54 Gleevec 54 sevelamer 54 abatacept Orencia 54 panitumumab Vectibix 54 MyVax 54 CYCLOSET 54 vildagliptin 54 STELARA 54 Qnexa 54 Triolex 54 FavId 54 Trastuzumab 54 erlotinib Tarceva 54 STRIDE PD 54 Troxatyl 54 TNF inhibitor 54 HUMIRA 54 Eli Lilly Gemzar 54 odanacatib 54 irbesartan 54 Pemetrexed 54 azathioprine 54 pemetrexed 54 systemic lupus erythematosus 54 QVA# 54 SNT MC# 54 Thalomid ® 54 neuroendocrine tumors 54 multiple myeloma MM 54 Aptivus ® 54 HRPC 54 ® natalizumab 54 abiraterone acetate 54 Adalimumab 54 selegiline 54 Ranexa 54 5-FU/LV 54 APOPTONE 54 placebo controlled clinical 54 undetectable HCV RNA 54 Tamibarotene 54 volociximab 54 Dacogen decitabine 54 Romidepsin 54 PROSTVAC TM 54 Fabry Disease 54 relapsing remitting 54 virologic failure 54 relapsed ovarian cancer 54 vosaroxin 54 thalidomide Thalomid 54 IV NSCLC 54 Liraglutide 54 Renagel 54 ACTEMRA TM 54 relapsing forms 54 ToGA 54 Neurodex 54 systemic lupus erythematosus SLE 54 KRN# 54 PREOS 54 APTIVUS r 54 TKI therapy 54 tumor progression 54 TYZEKA 54 Replagal 54 Nplate 54 Fibrillex TM 54 IMGN# 54 Arzerra 54 REYATAZ R 54 ZEVALIN 54 RRMS patients 54 rivaroxaban 54 mutated KRAS 54 NLX P# 54 metastatic renal cell 54 MabThera Rituxan 54 Panitumumab 54 oral FTY# 54 CHOP chemotherapy 54 Cloretazine 54 Aliskiren 54 beta interferons 54 letrozole Femara 54 EndoTAG TM -1 54 EFAPROXYN 54 nab paclitaxel 54 HSCT 54 AVADO 54 RSD# 54 Cimzia TM 54 Sensipar 54 refractory epilepsy 54 golimumab 54 Dimebon 54 sustained virologic response 54 Emselex 54 angiogenesis inhibitor 54 NovoTTF 54 glitazones 54 Sutent 54 INC# 54 Hepsera 54 ISIS # 54 ticagrelor 54 schizophrenia CIAS 54 UPLYSO 54 Specifid 54 Octreotide 54 Zevalin 54 candesartan 54 metastatic CRC 54 ranibizumab 54 hormone refractory prostate cancer 54 telcagepant 54 certolizumab 54 paliperidone palmitate 54 iclaprim 54 Gabapentin GR 54 standard chemotherapy regimen 54 sustained virological response 54 Huntexil 54 Boceprevir 54 Nexavar sorafenib 54 paliperidone ER 54 frovatriptan 54 Pixantrone 54 huC# DM4 54 Vfend 54 Northera 54 LEUKINE 54 rFIXFc 54 virologic response 54 Vimpat ® 54 Atrasentan 54 Azixa 54 diabetic macular edema 54 Zalbin 54 ustekinumab 54 brivaracetam 54 Azilect 54 RITUXAN 54 reslizumab 54 Erlotinib 54 Pioglitazone 54 omacetaxine 54 Vandetanib 54 GRN#L 54 levosimendan 54 idraparinux 54 TELINTRA 54 Camptosar 54 secondary efficacy endpoints 54 ARCALYST 54 ZYBRESTAT 54 Factor Xa inhibitor 54 darusentan 54 Trexima 54 LHRH agonists 54 antithrombotics 54 Arimoclomol 54 anticancer therapy 54 Bronchitol 54 carvedilol 54 VEGF inhibitors 54 CLL 54 Aromasin 54 PARP inhibitor 54 preoperative chemotherapy 54 TTF Therapy 54 PegIntron 54 brain metastases 54 Pegasys plus Copegus 54 linaclotide 54 Neulasta ® 54 complete remissions 54 fluvastatin 54 IGIV 54 metastatic RCC 54 HuMax EGFr 54 AVONEX ® 54 Aplidin 54 fostamatinib 54 Revimmune 54 antidiabetic 54 lasofoxifene 54 Tracleer 54 Bicifadine 54 rilonacept 54 Omacetaxine 54 retinal vein occlusion 54 tamoxifen therapy 54 Allovectin 7 54 Cladribine 54 ancrod 54 Vorapaxar 54 lorcaserin 54 pegylated liposomal doxorubicin 54 oral ridaforolimus 54 Pertuzumab 54 interferon alpha 54 asenapine 53 Antegren 53 UVIDEM 53 NATRECOR R 53 PEG PAL 53 Telaprevir 53 TOLAMBA 53 leukemia AML 53 superficial bladder cancer 53 uric acid lowering 53 bicalutamide 53 treprostinil 53 FAMPYRA 53 gefitinib 53 tumor shrinkage 53 HGS ETR1 53 eosinophilic asthma 53 severe hypercholesterolemia 53 IFN α 53 Gemcitabine 53 Pegintron 53 Androxal TM 53 surrogate endpoint 53 Ilaris 53 OncoVEX GM CSF 53 EOquin TM 53 T2DM 53 VEGF Trap 53 omecamtiv mecarbil 53 5FU 53 Omnitarg 53 certolizumab pegol 53 Hycamtin 53 THALOMID 53 clinically meaningful 53 fampridine 53 albinterferon alfa 2b 53 TACE 53 6R BH4 53 NVA# 53 metastatic lung cancer 53 gastrointestinal stromal tumor GIST 53 XGEVA 53 sunitinib Sutent 53 ramelteon 53 midstage studies 53 Xiaflex 53 satraplatin 53 nesiritide 53 Prestara 53 Galvus 53 mTOR inhibitors 53 fampridine SR 53 vernakalant hydrochloride 53 simvastatin 53 Satraplatin 53 AGGRASTAT ® 53 EVIZON 53 Sanofi Aventis Taxotere 53 ZOLINZA 53 Everolimus 53 Onconase 53 ThGRF 53 heavily pretreated patients 53 Preos 53 interferon beta therapy 53 ARCOXIA 53 MOZOBIL 53 OXi# 53 MACUGEN 53 chronic myeloid leukemia CML 53 CRx 53 TNFerade 53 relapsed multiple myeloma 53 HQK 53 Gliadel Wafer 53 Vitaxin 53 blinatumomab 53 Removab 53 zanolimumab 53 pegfilgrastim 53 non metastatic osteosarcoma 53 anti angiogenic therapy 53 Fablyn 53 Raptiva ® 53 bosutinib 53 Flurizan 53 metastatic hormone refractory 53 motesanib 53 cholinesterase inhibitor 53 CAPHOSOL 53 gemcitabine Gemzar 53 TYSABRI natalizumab 53 Glypromate 53 taranabant 53 disease progression 53 gastrointestinal stromal tumors 53 MoxDuo IR 53 tolevamer 53 Nanobody 53 Krystexxa 53 concomitant medications 53 Sutent sunitinib 53 tecarfarin 53 IFN beta 53 agomelatine 53 gabapentin 53 duloxetine 53 DEB# 53 dasatinib Sprycel 53 anti TNF alpha 53 Proleukin 53 ULORIC 53 postoperative ileus 53 neratinib 53 trastuzumab Herceptin 53 MYDICAR ® 53 HCD# [002] 53 Benlysta belimumab 53 Soliris 53 Epratuzumab 53 #mg dose [001] 53 Fx #A 53 DXL# 53 ELACYT 53 metaglidasen 53 Vidofludimus 53 MDV# 53 bazedoxifene 53 vicriviroc 53 renal cell carcinoma 53 Lacosamide 53 NEUPOGEN 53 CYT# 53 elinogrel 53 olmesartan 53 fulvestrant 53 exenatide once 53 relapsed MM 53 ezogabine 53 TAXUS Stent 53 Azilect ® 53 chemoresistant 53 registrational trial 53 donepezil 53 Xelox 53 Clolar ® 53 pradefovir 53 Urocidin 53 metformin sulfonylurea 53 antithrombotic 53 Cladribine Tablets 53 evaluating tivozanib 53 Sanctura XR 53 irinotecan 53 ADAGIO study 53 Pirfenidone 53 oxymorphone ER 53 maribavir 53 Pimavanserin 53 interferon alfa 53 Xeloda 53 rHuPH# 53 Elotuzumab 53 DU #b 53 raltegravir 53 Cinquil 53 Noxafil 53 pediatric acute lymphoblastic 53 Roche Actemra 53 tanezumab 53 Erbitux cetuximab 53 clopidogrel Plavix 53 levodopa therapy 53 Phase 2b study 53 Rituxan rituximab 53 Cloretazine R VNP#M 53 citalopram 53 methotrexate monotherapy 53 oritavancin 53 IL# PE#QQR 53 K ras mutations 53 Phase Ib 53 statin 53 intravenous cyclophosphamide 53 Ventavis 53 rNAPc2 53 Targretin capsules 53 GA GCB 53 rhThrombin 53 evaluable 53 lomitapide 53 erlotinib 53 ularitide 53 cell lymphoma CTCL 53 allogeneic stem cell 53 desvenlafaxine succinate 53 opioid induced bowel dysfunction 53 vemurafenib 53 alkylating agent 53 clodronate 53 levodopa 53 vernakalant 53 maraviroc 53 immunomodulatory therapy 53 fenretinide 53 Combidex 53 alvespimycin 53 belatacept 53 achieved ACR# 53 bortezomib Velcade 53 SCH # 53 anti TNFs 53 icatibant 53 recurrent glioblastoma multiforme 53 ENBREL 53 crizotinib 53 rhIGF-I/rhIGFBP-3 53 antihypertensive therapy 53 zileuton CR 53 antiangiogenic therapy 53 zileuton 53 OHR/AVR# 53 AVONEX 53 Factor VIIa 53 PhosLo 53 Lapatinib 53 haematologic malignancies 53 Advagraf 53 SCD HeFT 53 Nuedexta 53 placebo controlled Phase 53 tolerability profiles 53 ImClone Erbitux 53 Desmoteplase 53 oral antidiabetic 53 Chemophase 53 voreloxin 53 Alzhemed 53 omacetaxine mepesuccinate 53 TNF alpha inhibitor 53 Proxinium TM 53 Numax 53 angiographic outcomes 53 Archexin 53 ruboxistaurin 53 infliximab Remicade 53 lenalidomide 53 Pivotal Phase III 53 donepezil Aricept 53 Eribulin 53 PEG SN# 53 endoscopic remission 53 aromatase inhibitor 53 ciclosporin 53 Neuradiab 53 lipid lowering drugs 53 pancreatic insufficiency 53 PASI scores 53 mTOR inhibitor 52 HAART regimen 52 aripiprazole 52 ASONEP 52 Adentri 52 eniluracil 52 BYDUREON

Back to home page